Skip to content

Dr. Reddy's launches anti-cancer medication in China

Dr. Reddy's Abiraterone Acetate is the first Indian anti-cancer medication to be launched in China.

(Source- Twitter/ Vikram Misri)

Dr. Reddy's Laboratories, located in Hyderabad, has become the first Indian pharmaceutical organization to offer an anti-cancer medication in the Chinese market, according to India's ambassador to China, Vikram Misri, on October 13.

Abiraterone Acetate, which was launched in the US in 2020 is used to treat prostate cancer. This week brought some good news for the Indian pharmaceutical sector, as Abiraterone by Dr. Reddy's became the first anti-cancer medication from India to reach the Chinese market, Misri tweeted. Expect even greater success in this area, he added.

This post is for paying subscribers only


Already have an account? Log in